NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
72603-170-01 | 72603-170 | HUMAN PRESCRIPTION DRUG | Fludrocortisone Acetate | Fludrocortisone Acetate | TABLET | ORAL | 20230907 | N/A | ANDA | ANDA215279 | NorthStar Rx LLC | FLUDROCORTISONE ACETATE | .1 mg/1 | 100 TABLET in 1 BOTTLE (72603-170-01) |
71335-2454-1 | 71335-2454 | HUMAN PRESCRIPTION DRUG | Fludrocortisone Acetate | Fludrocortisone Acetate | TABLET | ORAL | 20240730 | N/A | ANDA | ANDA215279 | Bryant Ranch Prepack | FLUDROCORTISONE ACETATE | .1 mg/1 | 100 TABLET in 1 BOTTLE (71335-2454-1) |
70954-252-10 | 70954-252 | HUMAN PRESCRIPTION DRUG | Fludrocortisone Acetate | Fludrocortisone Acetate | TABLET | ORAL | 20220602 | N/A | ANDA | ANDA215279 | Novitium Pharma LLC | FLUDROCORTISONE ACETATE | .1 mg/1 | 30 TABLET in 1 BOTTLE (70954-252-10) |
70954-252-20 | 70954-252 | HUMAN PRESCRIPTION DRUG | Fludrocortisone Acetate | Fludrocortisone Acetate | TABLET | ORAL | 20220602 | N/A | ANDA | ANDA215279 | Novitium Pharma LLC | FLUDROCORTISONE ACETATE | .1 mg/1 | 100 TABLET in 1 BOTTLE (70954-252-20) |
70954-252-30 | 70954-252 | HUMAN PRESCRIPTION DRUG | Fludrocortisone Acetate | Fludrocortisone Acetate | TABLET | ORAL | 20220602 | N/A | ANDA | ANDA215279 | Novitium Pharma LLC | FLUDROCORTISONE ACETATE | .1 mg/1 | 500 TABLET in 1 BOTTLE (70954-252-30) |